Log in
Login
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Euronext Paris  >  PCAS    PCA   FR0000053514

PCAS (PCA)

Delayed Quote. Delayed  - 06/24 05:35:05 pm
10 EUR   -3.94%
06/22 PCAS : confirms its PME SME eligibility
06/07 PCAS : Collaboration Syngenta
06/07 PCAS : Syngenta Collaboration
SummaryQuotesChartsNewsCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector news 

PCAS : Extension of the manufacturing between VLG Chem and Sanofi

share with twitter share with LinkedIn share with facebook
share via e-mail
0
12/29/2011 | 11:11am CEST
Extension of the manufacturing contract between VLG Chem and  Sanofi until 2015 The PCAS Group and the Sanofi Group have signed an agreement on the extension of the manufacturing contract related to VLG Chem, a 100% PCAS subsidiary, until 2015. About PCAS PCAS is a fine and specialty chemicals group that shares an ambition for excellence with its customers, which primarily include market-leading international groups. PCAS designs and delivers the best industrial solutions for its customers' specific expectations. These various expectations all share a common demand for safety, quality, competitiveness, innovation and sustainability.
Longjumeau, december 27th, 2011
share with twitter share with LinkedIn share with facebook
share via e-mail
0
React to this article
Latest news on PCAS
06/22 PCAS : confirms its PME SME eligibility
06/07 PCAS : Collaboration Syngenta
06/07 PCAS : Syngenta Collaboration
06/06 PCAS : A new collaboration for enzyme optimization between syngenta and protéus ..
06/06 PCAS : A new collaboration for enzyme optimization between syngenta and protéus ..
05/24 PCAS : Allocation of free shares
04/28 PCAS : Corporate name change
04/27 PCAS : Corporate name change
04/27 PCAS : ex-dividend day for final dividend
04/25 PCAS : enters into a manufacturing agreement with ABIVAX
Advertisement
News chart
Full-screen chart
Income Statement Evolution
More Financials